Moderna Inc (NASDAQ:MRNA) currently has a daily average trading volume of 4.57M but it saw 4094778 shares traded in last market. With a market cap of 24.28B USD, the company’s current market price of $63.16 came falling about -1.20 while comparing to the previous closing price of $63.93. In past 52 weeks, the stock remained buoying in the range of price level as high as $170.47 and as low as $62.55. In the recent trading on the day, stock has struck highest price mark of $62.58 while lowest mark touched by it was $63.69.
Taking a look at 20-day trading activity of Moderna Inc (MRNA) gives us an average price of $68.99, while its current price level is -62.95% below from 52-week high level whereas it is 0.98% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $81.69 while that of 200 days or SMA-200 reads an average of $105.27. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.83% during that period while stretching the period over a month that increases to 4.54%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 31.49 which implies that the stock is in neutral territory.
JP Morgan downgraded its recommendation for the stock as a “Underweight” from “Neutral” on September 13, 2024 while assigning a price target range of $88-$70. Jefferies also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $120 and $65.
Over the week, MRNA’s stock price is moving -0.75% down while it is -13.41% when we observe its performance for the past one month. Year-to-date it is -36.49% down and over the past year, the stock is showing a downside performance of -38.86%.
Currently, Moderna Inc’s total number of outstanding shares is 382.00M. Company’s return on investment (ROI) stands at -45.28% and return on equity (ROE) at -40.94%. Stock’s beta reads 1.67. Stock has a price to book (P/B) ratio of 2.07 while price to sale or P/S ratio amounts to 4.82. Its return on asset (ROA) is -31.24% on average.
